Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial
Noriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, Sakiko Kimura, Kazuhisa Hosoya, Yuya Shinkawa, Takuma Furukawa, Tsubasa Mitsutake · 2026
Read Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial by Noriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, Sakiko Kimura, Kazuhisa Hosoya, Yuya Shinkawa, Takuma Furukawa, Tsubasa Mitsutake (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353127.txt.
Description
Noriko Yoshida and seven co-authors describe this 2026 PLOS One protocol for the SACLA trial. The trial is a phase II study of surgery for bleeding under the center of the retina. Such bleeding can blind patients with macular degeneration. Twenty patients will have a vitrectomy, then an injection of a clot-dissolving drug under the retina. The trial runs partly in decentralized form. Later check-ups can happen at partner sites, to spare patients travel.
As a protocol, the paper sets out the design, not results. The main measure is change in the thickness of the retina's center, one week after surgery. Vision and safety will be tracked for twelve weeks. No drug is yet approved for this use. The authors aim for the first prospective proof on whether this approach is feasible and safe.
Catalog record
| CREATOR | Noriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, Sakiko Kimura, Kazuhisa Hosoya, Yuya Shinkawa, Takuma Furukawa, Tsubasa Mitsutake |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41058 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |